<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> is the substitution of the esophagus distal epithelium (scaly) by another one of columnar type (<z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath>) </plain></SENT>
<SENT sid="1" pm="."><plain>It is due to the gastroesophageal or <z:e sem="disease" ids="C0013299" disease_type="Disease or Syndrome" abbrv="">duodenogastric reflux</z:e> and other genetic and gotten factors </plain></SENT>
<SENT sid="2" pm="."><plain>In the diagnosis it is essential to discover the existence and grade of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> which constitute the pre-malignant stage of the <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> by which vigilance is very important </plain></SENT>
<SENT sid="3" pm="."><plain>The treatment is the same as the one of <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo> and there is no agreement about the advantages of the medical and the surgical treatment </plain></SENT>
<SENT sid="4" pm="."><plain>The medication (IBP) is effective against the <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> but doesn't control the duodenogastric in contrast to the surgery (antireflux techniques) which is also cheaper and in recent studies it seems to control the <z:mpath ids='MPATH_589'>dysplasia</z:mpath> progress </plain></SENT>
</text></document>